140639-94-7

Basic information

• Product Name: Benzenemethanol, 3-(1,3-dioxolan-2-yl)-
• CAS NO: 140639-94-7
• Molecular Formula: C10H12O3
• Molecular Weight: 180.203
• Mol File: 140639-94-7.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Benzenemethanol, 3-(1,3-dioxolan-2-yl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanol, 3-(1,3-dioxolan-2-yl)-(140639-94-7)
• EPA Substance Registry System: Benzenemethanol, 3-(1,3-dioxolan-2-yl)-(140639-94-7)

Safety Data

• Hazardous Substances Data: 140639-94-7(Hazardous Substances Data)

Upstream product

• 17789-14-9 3-(1,3-dioxolan-2-yl)-phenylbromide 
• 626-19-7 Isophthalaldehyde 
• 52178-50-4 Methyl 3-formylbenzoate 
• 124791-75-9 methyl 4-(2,2-dimethoxyethyl)benzoate 
• 119770-37-5 methyl 4-[(E)-2-methoxyethenyl]benzoate 
• 1571-08-0 methyl 4-formylbenzoate 
• 124038-36-4 3-[1,3]Dioxolan-2-yl-benzoic acid methyl ester 
• 68348-23-2 3-(1,3-dioxolan-2-yl)benzaldehyde 
• 107-21-1 ethylene glycol 

Downstream Products

• 28746-20-5 3-(methoxymethyl)benzaldehyde 
• 52010-98-7 3-(hydroxymethyl)benzaldehyde 
• 922525-34-6 C₁₂H₁₇NO 
• 203940-48-1 methyl 4-({[1-(3-hydroxymethylphenyl)-2-nitroethyl]thio}methyl)benzoate 
• 203940-49-2 methyl (±)-4-({[2-amino-1-(3-hydroxymethylphenyl)ethyl]thio}methyl)benzoate 
• 203940-50-5 methyl 4-({[2-(4-chlorophenylsulfonylamino)-1-(3-hydroxymethylphenyl)ethyl]thio}methyl)benzoate 
• 203940-51-6 methyl 4-({[2-(4-chlorophenylsulfonylamino)-1-(3-formylphenyl)ethyl]thio}methyl)benzoate 
• 203940-25-4 (+/-)-methyl 4-{[(2-{4-chlorophenylsulfonylamino}-1-{3-[(E)-2-(7-chloro-2-quinolyl)vinyl]phenyl}ethyl)thio]methyl}benzoate 

Relevant articles and documents

Synthesis of 16β-derivatives of 3-(2-bromoethyl)-estra-1,3,5(10)-trien-17β-ol as inhibitors of 17β-HSD1 and/or steroid sulfatase for the treatment of estrogen-dependent diseases

17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) and steroid sulfatase (STS) are involved in the synthesis of the most potent estrogen in the human body, estradiol (E2). These enzymes are known to play a pivotal role in the progression of estrogen-depen

COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY

The present invention relates to compounds acting both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists, to processes for their preparation, to compositions comprising them, to therapeutic uses and combinations with other pharmaceutical active ingredients.

COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY

Compounds of formula (I) described herein act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for the prevention and/or treatment of broncho-obstructive or inflammatory diseases.